Evidence map›Paper›PMID 33512028›Full record

Trial reportEuropean journal of pain (London, England)2021

Effectiveness of a structured group intervention based on pain neuroscience education for patients with fibromyalgia in primary care: A multicentre randomized open-label controlled trial.

María Jesús Barrenengoa-Cuadra, María Muñoa-Capron-Manieux, Marian Fernández-Luco, Luis Ángel Angón-Puras, Ana J Romón-Gómez, Maider Azkuenaga, Amaia Etxebarria, Gixane Orrantia, Ainhoa Pikaza, Lourdes Uribe-Etxebarria and 5 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European journal of pain (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

María Jesús Barrenengoa-CuadraPrimary Health Care Center Sáenz de Buruaga, Osakidetza Basque Health Service, OSI Bilbao-Basurto, Bilbao, Spain.
María Muñoa-Capron-ManieuxWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Marian Fernández-LucoWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Luis Ángel Angón-PurasWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Ana J Romón-GómezWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Maider AzkuenagaWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Amaia EtxebarriaWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Gixane OrrantiaWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Ainhoa PikazaWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Lourdes Uribe-EtxebarriaWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Ana ZorrillaWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
Gorka LarrinagaDepartment of Nursing, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
Eunate Arana-ArriBiocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.
Rafael Gracia-BallarínWorking Group on Fibromyalgia, Migraine and Chronic Pain, Osatzen Sociedad Vasca de Medicina Familiar y Comunitaria, Bilbao, Spain.
FIMIDOC Working Group researchers
Sociedad Andaluza de Medicina Familiar y Comunitaria · ESHospital de Basurto · ESOsakidetza · ESBioCruces Health research Institute · ESMadrid Health Service · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere has been increased interest in pain neuroscience education (PNE) as a therapeutic approach for the management of fibromyalgia (FM).

methodsA multicentre randomized, open-label, controlled trial was conducted to assess the effectiveness of a structured group intervention based on PNE in patients with FM. A total of 139 patients were included in the study and randomized to the intervention group (7 group sessions of education in neurobiology of pain) or to the control group (treatment as usual only). The primary outcome was the improvement of functional status and pain measured with the Fibromyalgia Impact Questionnaire (FIQ), and secondary outcomes were the reduction in the impact of pain and other symptoms (catastrophizing, anxiety and depression) and number of patients reaching no worse than moderate functional impairment (FIQ score <39). Differences between groups were calculated by linear mixed-effects (intention-to-treat approach) and mediational models through path analyses.

resultsAt 1 year, improvements in FIQ scores were higher in the intervention group with moderate or high effect size, and decreases of ≥20% in 69.1% of patients (20.9% in the control group) and of ≥50% in 39.7% (4.5% in the control group). Also, 52.9% of patients had a FIQ <39 points (13.4% in the control group).

conclusionsIn this sample of patients with FM, the improvement in quality of life and control of symptoms obtained by adding a PNE intervention showed promising results, equalling or surpassing previously reported outcomes. SIGNIFICANCE: A structured group intervention based on pain neuroscience education for 1 year in patients with fibromyalgia was associated with significant amelioration of the impact of the disease on scores of the Fibromyalgia Impact Questionnaire, the Health Assessment Questionnaire, the Hospital Anxiety and Depression Scale, the Pain Catastrophizing Scale and the Polysymptomatic Distress Scale as compared with only treatment as usual. These findings are clinically relevant considering the challenges posed by fibromyalgia to clinicians and patients alike.

Indexed as

FibromyalgiaHumansPainPain MeasurementPrimary Health CareQuality of LifeTreatment Outcome

Identifiers

PMID33512028
PMCPMC8247853
OpenAlexW3125155960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.